These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 24486850)

  • 1. Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence.
    Shanmugam MK; Dai X; Kumar AP; Tan BK; Sethi G; Bishayee A
    Cancer Lett; 2014 May; 346(2):206-16. PubMed ID: 24486850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triterpenoids as new promising anticancer drugs.
    Petronelli A; Pannitteri G; Testa U
    Anticancer Drugs; 2009 Nov; 20(10):880-92. PubMed ID: 19745720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling.
    Gao X; Deeb D; Jiang H; Liu Y; Dulchavsky SA; Gautam SC
    J Neurooncol; 2007 Sep; 84(2):147-57. PubMed ID: 17361329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids.
    Borella R; Forti L; Gibellini L; De Gaetano A; De Biasi S; Nasi M; Cossarizza A; Pinti M
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31766211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.
    Hyer ML; Shi R; Krajewska M; Meyer C; Lebedeva IV; Fisher PB; Reed JC
    Cancer Res; 2008 Apr; 68(8):2927-33. PubMed ID: 18413762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells.
    Shishodia S; Sethi G; Konopleva M; Andreeff M; Aggarwal BB
    Clin Cancer Res; 2006 Mar; 12(6):1828-38. PubMed ID: 16551868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-{kappa}B signaling proteins in colorectal cancer cells.
    Gao X; Deeb D; Hao J; Liu Y; Arbab AS; Dulchavsky SA; Gautam SC
    Anticancer Res; 2010 Mar; 30(3):785-92. PubMed ID: 20392997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.
    Deeb D; Gao X; Jiang H; Dulchavsky SA; Gautam SC
    Prostate; 2009 Jun; 69(8):851-60. PubMed ID: 19189297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells.
    Wang YY; Yang YX; Zhao R; Pan ST; Zhe H; He ZX; Duan W; Zhang X; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():993-1026. PubMed ID: 25733817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer activity of oleanolic acid and its derivatives: Recent advances in evidence, target profiling and mechanisms of action.
    Tang ZY; Li Y; Tang YT; Ma XD; Tang ZY
    Biomed Pharmacother; 2022 Jan; 145():112397. PubMed ID: 34798468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.
    Wang YY; Yang YX; Zhe H; He ZX; Zhou SF
    Drug Des Devel Ther; 2014; 8():2075-88. PubMed ID: 25364233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells.
    Deeb D; Gao X; Dulchavsky SA; Gautam SC
    Anticancer Res; 2007; 27(5A):3035-44. PubMed ID: 17970042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment.
    Wang YY; Zhe H; Zhao R
    Mol Cancer; 2014 Feb; 13():30. PubMed ID: 24552536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Cancer Potential of Synthetic Oleanolic Acid Derivatives and Their Conjugates with NSAIDs.
    Baer-Dubowska W; Narożna M; Krajka-Kuźniak V
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
    Deeb D; Gao X; Dulchavsky SA; Gautam SC
    J Exp Ther Oncol; 2008; 7(1):31-9. PubMed ID: 18472640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic oleanane triterpenoid, CDDO-Me, induces apoptosis in ovarian cancer cells by inhibiting prosurvival AKT/NF-κB/mTOR signaling.
    Gao X; Liu Y; Deeb D; Arbab AS; Guo AM; Dulchavsky SA; Gautam SC
    Anticancer Res; 2011 Nov; 31(11):3673-81. PubMed ID: 22110186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent.
    Vannini N; Lorusso G; Cammarota R; Barberis M; Noonan DM; Sporn MB; Albini A
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3139-46. PubMed ID: 18065492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes.
    Yates MS; Tauchi M; Katsuoka F; Flanders KC; Liby KT; Honda T; Gribble GW; Johnson DA; Johnson JA; Burton NC; Guilarte TR; Yamamoto M; Sporn MB; Kensler TW
    Mol Cancer Ther; 2007 Jan; 6(1):154-62. PubMed ID: 17237276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthetic triterpenoid CDDO-methyl ester delays estrogen receptor-negative mammary carcinogenesis in polyoma middle T mice.
    Tran K; Risingsong R; Royce D; Williams CR; Sporn MB; Liby K
    Cancer Prev Res (Phila); 2012 May; 5(5):726-34. PubMed ID: 22401982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways.
    Chintharlapalli S; Papineni S; Konopleva M; Andreef M; Samudio I; Safe S
    Mol Pharmacol; 2005 Jul; 68(1):119-28. PubMed ID: 15798084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.